Febrile neutropenia is a serious condition that can be fatal if not treated early.

If you are a doctor, you may be required to calculate the risk of this condition in patients you treat.

To help you with this task, ONCOFoCUS Febrile Neutropenia Risk Assessment tool has been developed.

This tool is designed to calculate the probability of patients developing Febrile neutropenia after they have been treated with a certain drug.

Using the tool, you can calculate the risk of patients developing this condition after they have been treated with a specific drug.

The application also provides you with a series of questions, based on the guidelines from the European Organisation for the Treatment of Cancer (EORTC) and the National Cancer Commission (NCCN).